Aethlon Medical (AEMD)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 03/31
| 06-2024 | 03-2024 | 12-2023 | 09-2023 | 06-2023 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 9,072 | 5,442 | 7,972 | 10,176 | 12,898 |
| Other current assets | 0 | 278 | 0 | 0 | 0 |
| TOTAL | $9,550 | $6,226 | $8,249 | $10,487 | $13,308 |
| Non-Current Assets | |||||
| PPE Net | 929 | 1,015 | 1,114 | 1,200 | 1,284 |
| Intangibles | 1 | 1 | 1 | 1 | 2 |
| Other Non-Current Assets | 935 | 1,004 | 1,072 | 1,140 | 1,207 |
| TOTAL | $1,865 | $2,020 | $2,187 | $2,341 | $2,493 |
| Total Assets | $11,415 | $8,246 | $10,437 | $12,828 | $15,801 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 1,068 | 778 | 693 | 685 | 845 |
| Other current liabilities | 765 | 762 | 1,122 | 746 | 703 |
| TOTAL | $2,129 | $1,830 | $2,101 | $1,711 | $1,822 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 574 | 650 | 725 | 799 | 870 |
| TOTAL | $574 | $650 | $725 | $799 | $870 |
| Total Liabilities | $2,703 | $2,480 | $2,826 | $2,509 | $2,692 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 174 | 174 | 33 | 31 | 31 |
| Common Shares | 14 | 0 | 3 | 3 | 25 |
| Retained earnings | -157,138 | -154,567 | -152,141 | -148,675 | -145,641 |
| Other shareholders' equity | -8 | -7 | -2 | -10 | -7 |
| TOTAL | $8,713 | $5,766 | $7,611 | $10,319 | $13,109 |
| Total Liabilities And Equity | $11,415 | $8,246 | $10,437 | $12,828 | $15,801 |